HCV-Smoking Cessation Study

Prisma Health-Upstate

Status: Completed

Conditions: Hepatitis C; Smoking Cessation

Treatments: Behavioral: Cognitive Behavioral Counseling

Study type: Interventional

Funder types: Other

Identifiers

NCT05466981

00103095

Details and patient eligibility

About

A 12-week study for patients who are being treated for Hepatitis C and would like to quit smoking. During the 12 weeks of Hepatitis C treatment, the research team will have counseling sessions with the participants to discuss challenges related to Hepatitis C and smoking.

Full description

A 12-week smoking cessation intervention addressing concurrently HCV and smoking cessation The Standard of care for HCV is 12 weeks of oral medication with 3 in-person provider/laboratory visits throughout. This study utilizes both in-person and phone counseling and health education sessions. Each session will address a different topic related to HCV, smoking, and how both smoking and HCV affect health and quality of life.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults (≥18 years old)
• Current HCV infection (HCV RNA+)
• Current cigarette smoking
• Patients in contemplation / preparation stage of change

Exclusion criteria

• Inability to speak/read English, as materials will be provided in English
• Current suicidal ideation as determined by the PHQ-9, requiring a greater level of clinical care
• Severe medical or psychiatric disability that prevents participant from ability to comprehend or consent to study

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

Current smokers with an HCV infection

Experimental group

Description:

Persons who currently smoke cigarettes and are also HCV RNA+

Treatment:

Behavioral: Cognitive Behavioral Counseling